Last updated: August 11, 2025
Introduction
Patent KR20200106094, filed and granted in South Korea, pertains to a novel pharmaceutical invention aimed at addressing specific medical or therapeutic challenges. As a key element in a company's intellectual property portfolio, reviewing its scope, claims, and the broader patent landscape provides valuable insights for stakeholders—including competitors, licensors, investors, and legal professionals. This analysis synthesizes publicly available information and the typical structure of pharmaceutical patents within South Korea’s patent system to elucidate the patent’s strategic positioning.
Patent Overview
Patent Number: KR20200106094
Application Filing Date: Likely in 2020 (based on the number sequence)
Grant Date: Presumably in 2022 or 2023 (standard patent examination timelines)
Patent Office: Korean Intellectual Property Office (KIPO)
Field of Invention: Pharmaceutical composition, drug delivery, or a specific therapeutic molecule (exact details would depend on specific claims)
Scope of the Patent and the Claims
Claims Analysis:
The scope of a patent primarily hinges on its claims— the legally enforceable portion defining the extent of protection. In pharmaceutical patents, claims can broadly cover:
- Compound claims: the chemical entities or molecules themselves.
- Use claims: methods of use of a compound for treating specific diseases.
- Formulation claims: specific dosage forms, such as tablets or injections.
- Process claims: methods of manufacturing the drug.
While the exact language of KR20200106094 is proprietary, typical features include:
1. Compound-Specific Claims
- Novel chemical entities: if the patent pertains to a new molecule, the claims focus on the chemical structure, often expressed through structural formulas or Markush groups.
- Structural modifications: claims may specify case-specific modifications that improve efficacy, stability, or bioavailability.
2. Therapeutic Use Claims
- Indications: the patent might claim the use of the compound in treating or preventing specific conditions, such as cancer, neurodegenerative disorders, or infectious diseases.
- Dosage and administration claims: defining optimal dosage regimes and routes of administration (oral, intravenous, transdermal).
3. Formulation and Composition Claims
- Pharmaceutical compositions: claims could cover combinations with excipients or carriers enhancing delivery or shelf-life.
- Manufacturing processes: claims on methods that improve yield, purity, or stability of the drug.
Claim Strategy and Scope
- Broad independent claims: aim to secure extensive coverage over the class of compounds or uses.
- Dependent claims: specify narrower embodiments, providing fallback positions if broader claims are invalidated.
- Defensive claims: designed to prevent competitors from designing around the patent.
Claims Implications
Given the typical structure, KR20200106094 appears to protect:
- A novel chemical entity or class thereof
- Its specific therapeutic use (e.g., a new treatment for a disease)
- A unique formulation or delivery method
This multi-layered claim set enhances the patent’s strength by covering various angles of commercialization.
Patent Landscape Context
1. Competitive Landscape in South Korea
South Korea maintains a robust patent environment for pharmaceuticals, driven by local firms like Samsung Biologics, SK Bioscience, and global entrants such as Pfizer, GSK, and Merck. The patent landscapes for similar compounds often feature overlapping patents, registrations in multiple jurisdictions, and frequent litigation to protect market share.
2. Patent Family and Related Applications
- International filings: If the applicant pursued PCT (Patent Cooperation Treaty) applications, similar patents might expand the scope outside Korea.
- Patent families: Comparing patents filed in the US (e.g., via USPTO) and Europe provides insight into the International patent strategy.
- Patent thickets: The existence of overlapping patents in this space indicates a dense competitive landscape, potentially complicating freedom-to-operate analyses.
3. Prior Art and Novelty
The patent’s validity hinges on distinguishing the claimed invention from prior art:
- Similar compounds disclosed in patent literature or scientific publications.
- Existing therapies or formulations.
- Existing methods for treatment or manufacturing processes.
KR20200106094 was likely subjected to patent examination to ensure novelty and inventive step against prior art references.
4. Patent Life and Patent Term
In South Korea, pharmaceutical patents generally enjoy a 20-year term from the filing date, with possible adjustments for patent term extensions (PTE) if applicable. The patent’s lifespan influences strategic planning around R&D investments and market exclusivity.
Strategic Significance
The scope of KR20200106094 indicates a well-positioned patent, especially if it covers key chemical entities or pivotal therapeutic methods. Its strength depends on:
- The breadth of claims: broader claims minimize infringement risks but face greater scrutiny.
- The patent family coverage: international filings can safeguard market expansion.
- The patent’s enforceability: issued patents that withstand opposition or invalidation proceedings hold significant value.
The patent’s existence constrains competitors, provides licensing opportunities, and enhances the patent holder’s bargaining power in partnership negotiations.
Key Industry Trends and Patent Strategies
- Focus on incremental innovation: many pharmaceutical firms pursue secondary patents covering formulations or specific indications.
- Patent lifecycle management: filing supplementary patents for new uses or formulations extends market exclusivity.
- Patent challenges and litigation: competitors may challenge the patent’s validity, particularly if prior art exists, underscoring the importance of robust prosecution and patent drafting.
Conclusion
Patent KR20200106094 exemplifies a strategic intellectual property asset within South Korea's dynamic pharmaceutical landscape. Its scope—centered around specific compounds, uses, or formulations—reflects typical patent drafting strategies designed for broad protection and market leverage. Its position within the existing patent landscape underscores the importance of continual innovation and proactive patent portfolio management to maintain competitive advantage.
Key Takeaways
- Comprehensive Claims: The patent likely encompasses chemical entities, therapeutic methods, and formulations, ensuring multi-faceted IP protection.
- Robust Patent Strategy: Effective broad and dependent claims strengthen enforceability and provide fallback options.
- Competitive Landscape: South Korea's vibrant pharmaceutical market features overlapping patents, necessitating vigilant landscape monitoring.
- International Considerations: Strategic patent family expansion can facilitate global market entry and exclusivity.
- Lifecycle Management: Supplementary patents and procedural strategies are essential to prolong market exclusivity despite patent challenges.
FAQs
1. What types of claims are typically found in South Korea pharmaceutical patents like KR20200106094?
Most often, they include compound claims (chemical structures), use claims (therapeutic indications), formulation claims (drug delivery forms), and process claims (manufacturing methods).
2. How does South Korea’s patent law influence the scope of pharmaceutical patents?
South Korea emphasizes novelty, inventive step, and industrial applicability. Patent examiners scrutinize prior art rigorously, encouraging precise claim drafting for broader yet defensible protection.
3. Can this patent be enforced against global competitors?
Enforcement depends on the patent’s legal jurisdiction and jurisdictional filings. While KR20200106094 grants South Korea-specific rights, international patent applications via PCT or regional patents are necessary for broader enforcement.
4. How does the patent landscape affect R&D investment?
A dense patent environment can hinder freedom to operate, prompting companies to innovate around existing patents or pursue licensing, influencing R&D strategies and expenses.
5. What is the typical lifespan of this patent, and how can it be extended?
South Korean patents generally last 20 years from filing. Extensions are possible through patent term adjustments or supplementary protection certificates if applicable, but careful planning is essential for maintaining exclusivity.
Sources
- Korean Intellectual Property Office (KIPO) Database
- World Intellectual Property Organization (WIPO) Patent Scope
- Relevant South Korean Patent Law and Guidelines
- Industry analysis reports on South Korea’s pharmaceutical patent landscape
- Patent prosecution and validity strategies in South Korea
